Notes And Other Explanatory Information [Abstract]

Innate Pharma - Filing #5981200

Concept 2024-01-01 to
2024-12-31
Notes and other explanatory information [abstract]
Disclosure of accounting judgements and estimates [text block]
Disclosure of auditors' remuneration [text block]
Disclosure of authorisation of financial statements [text block]
Disclosure of basis of consolidation [text block]
Disclosure of borrowings [text block]
Disclosure of cash and cash equivalents [text block]
Disclosure of changes in accounting policies [text block]
Disclosure of commitments and contingent liabilities [text block]
Disclosure of credit risk [text block]
Disclosure of depreciation and amortisation expense [text block]
Disclosure of earnings per share [text block]
Disclosure of events after reporting period [text block]
Disclosure of expenses by nature [text block]
Disclosure of fair value of financial instruments [text block]
Disclosure of finance income (cost) [text block]
Disclosure of financial instruments at fair value through profit or loss [text block]
Disclosure of financial risk management [text block]
Disclosure of general information about financial statements [text block]
Disclosure of government grants [text block]
Disclosure of information about key management personnel [text block]
Disclosure of liquidity risk [text block]
Disclosure of market risk [text block]
Disclosure of material accounting policy information [text block]
Disclosure of other liabilities [text block]
Disclosure of other operating expense [text block]
Disclosure of other provisions, contingent liabilities and contingent assets [text block]
Disclosure of property, plant and equipment [text block]
Disclosure of related party [text block]
Disclosure of research and development expense [text block]
Disclosure of revenue [text block]
Disclosure of revenue from contracts with customers [text block]
Disclosure of share capital, reserves and other equity interest [text block]
Disclosure of subsidiaries [text block]
Disclosure of trade and other payables [text block]
Disclosure of trade and other receivables [text block]
Disclosure of treasury shares [text block]

Talk to a Data Expert

Have a question? We'll get back to you promptly.